Black Women Are Less Likely to Be Classified as High-Risk for Breast Cancer Using the Tyrer-Cuzick 8 Model.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 04 04 2022
accepted: 24 06 2022
pubmed: 6 7 2022
medline: 14 9 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

Breast cancer risk assessment is a powerful tool that guides recommendations for supplemental breast cancer screening and genetic counseling. The Tyrer-Cuzick 8 (TC8) model is widely used for calculating breast cancer risk and thus helps determine if women qualify for supplemental screening or genetic counseling. However, the TC8 model may underestimate breast cancer risk in Black women. This study sought to assess this disparity. Data on race, breast density, body mass index (BMI), and TC8 scores were retrospectively extracted from the electronic medical record (EMR). Logistic regressions were run to evaluate racial differences in TC8 scores. Summary and correlation statistics determined relationships between BMI, breast density, and race. Rank biserial correlations were employed to explore the impact of breast density and BMI on TC8 scores. Of 15,356 patients, 5796 were White and 5813 were Black. Black patients had higher rates of BMI ≥ 27 compared with White women (79.2% vs. 45.7%), lower rates of breast density (35.1% vs. 56.2%), and lower rates of high-risk TC8 scores (10.7% vs. 17.5%, OR = 1.6646). There was an inverse relationship between TC8 score and BMI (r Black women are less likely to have high-risk TC8 scores despite having only marginally lower breast cancer incidence rates and higher breast cancer mortality rates than White women. This suggests that the TC8 model underestimates breast cancer risk in Black women, possibly due to lower rates of breast density and higher BMIs among Black women.

Sections du résumé

BACKGROUND BACKGROUND
Breast cancer risk assessment is a powerful tool that guides recommendations for supplemental breast cancer screening and genetic counseling. The Tyrer-Cuzick 8 (TC8) model is widely used for calculating breast cancer risk and thus helps determine if women qualify for supplemental screening or genetic counseling. However, the TC8 model may underestimate breast cancer risk in Black women. This study sought to assess this disparity.
METHODS METHODS
Data on race, breast density, body mass index (BMI), and TC8 scores were retrospectively extracted from the electronic medical record (EMR). Logistic regressions were run to evaluate racial differences in TC8 scores. Summary and correlation statistics determined relationships between BMI, breast density, and race. Rank biserial correlations were employed to explore the impact of breast density and BMI on TC8 scores.
RESULTS RESULTS
Of 15,356 patients, 5796 were White and 5813 were Black. Black patients had higher rates of BMI ≥ 27 compared with White women (79.2% vs. 45.7%), lower rates of breast density (35.1% vs. 56.2%), and lower rates of high-risk TC8 scores (10.7% vs. 17.5%, OR = 1.6646). There was an inverse relationship between TC8 score and BMI (r
DISCUSSION CONCLUSIONS
Black women are less likely to have high-risk TC8 scores despite having only marginally lower breast cancer incidence rates and higher breast cancer mortality rates than White women. This suggests that the TC8 model underestimates breast cancer risk in Black women, possibly due to lower rates of breast density and higher BMIs among Black women.

Identifiants

pubmed: 35790586
doi: 10.1245/s10434-022-12140-9
pii: 10.1245/s10434-022-12140-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6419-6425

Informations de copyright

© 2022. Society of Surgical Oncology.

Références

Centers for Disease Control and Prevention. 2021. https://www.cdc.gov/cancer/breast/basic_info/index.htm . Accessed 1 Oct 2021.
Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111–30.
doi: 10.1002/sim.1668
Brentnall AR, Cuzick J. Risk models for breast cancer and their validation. Stat Sci. 2020;35(1):14–30.
doi: 10.1214/19-STS729
Kurian AW, Hughes E, Simmons T, et al. Performance of the IBIS/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the women’s health initiative. Cancer. 2021;127(20):3742–50.
doi: 10.1002/cncr.33767
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
doi: 10.3322/caac.21590
Bissell MCS, Kerlikowske K, Sprague BL, et al. Breast cancer population attributable risk proportions associated with body mass index and breast density by race/ethnicity and menopausal status. Cancer Epidemiol Biomark Prev. 2020;29(10):2048–56.
doi: 10.1158/1055-9965.EPI-20-0358
Hudson S, Hjerkind KV, Vinnicombe S, et al. Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk. Breast Cancer Res. 2018;20(1):156.
doi: 10.1186/s13058-018-1078-8
Boyd NF, Martin LJ, Sun L, et al. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomark Prev. 2006;15(11):2086–92.
doi: 10.1158/1055-9965.EPI-06-0345
Centers for Disease Control and Prevention. 2020. https://www.cdc.gov/nchs/products/databriefs/db360.htm . Accessed 1 Oct 2021.
Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol. 2018;15(3):408–14.
doi: 10.1016/j.jacr.2017.11.034

Auteurs

Melissa D Porterhouse (MD)

Rush Medical College, Chicago, IL, USA.

Shirlene Paul (S)

Rush University Cancer Center, Chicago, IL, USA.

Jordan L Lieberenz (JL)

Rush University Cancer Center, Chicago, IL, USA.

Lisa R Stempel (LR)

Rush University Cancer Center, Chicago, IL, USA.
Department of Radiology, Rush University Medical Center, Chicago, IL, USA.

Mia A Levy (MA)

Rush University Cancer Center, Chicago, IL, USA.
Division of Hematology, Oncology, and Stem Cell Transplant, Department of Medicine, Rush University Medical Center, Chicago, IL, USA.

Rosalinda Alvarado (R)

Rush University Cancer Center, Chicago, IL, USA. rosalinda_alvarado@rush.edu.
Division of Surgical Oncology, Department of Surgery, Rush University Medical Center, Chicago, IL, USA. rosalinda_alvarado@rush.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH